(*CSSA)
ONCOLOGY
Think safe. Work safe. Be safe.
In addition to surgery or radiotherapy, chemotherapy is an important pillar in combating cancer. The cytostatics used for chemotherapy belong to the CMR (Carcinogenic,Mutagenic, Reprotoxic) substances. Handling these hazardous drugs require special precautionary measures to ensure safety of hospital staff, along with protection of patients and their relatives. Exposure to cytostatics can be short-, medium- or long-term, and can lead to acute, mild or serious adverse events.
Short term (1)
Skin irritation
Headache
Nausea
Hair loss
Allergic reaction
Necrosis
Medium term (1)
Irritation
Infertility
Higher risk
Miscarriage
Congenital malformations
Long term (2)
Higher risk of leukemia
Increased risk for cancers
DNA change
The greatest risk of widespread contamination is, in preparation and administration of cytostatics
BEFORE : when connecting the cytostastic bag to the main IV Line.
DURING : when infusion line is not closed, with a CSSA, a wrong handling could lead to leakage of cytostatics.
AFTER : when disposing the infusion line, residual drugs may remain in the tubing and thus, despite flushing, expose HCP’s.
Surface contamination before and after introduction of a CSTD
By using a Closed System Transfer Device - CSTD (e.g. Qimono), surface contamination can be reduced by more than 96%. (3)
Study result:
Surface contamination without CSTD (78.2%) can be significantly reduced (2.6%) when using a CSTD.(3)
100 75 50 25
78,2%
2,6%
Screwless connection
• To eliminate over or under-tightening, misthreading
• To reduce repetitive strain injuries
Connectable to standard Luer devices
• To connect standard Luer slip / Luer lock devices (i.e. : syringes, extension lines, …)
Direct fluid pathway
• To make aspiration and injection easier
• To allow effective flushing
Material resistant to aggressive solvents
• To avoid cracking of medical devices
Barrier against toxic drugs and bacteria
• To protect users from chemical contamination and the drugs from bacteriological contamination
Easy disinfection of both ♀ and ♂ hubs
• To be able to disconnect and connect again devices if needed
Valves automatically close on disconnection
+ Proximal end Female Luer lock connector Compatible with all male luer lock connectors
Chemo NaCl
+ Safety lock mechanism Secure connection through spinning locking system
+ Bayonet system
Easy to disinfect Automatic membrane closure after disconnection (split septum technology)
+ Distal end Compatible with qimo
+ Famel Luer Lock connector
Compatible with standard Luer systems (syringes, infusion lines, etc.)
Automatic membrane closure after disconnection (split septum technology)
+ Distal end Male Luer Lock connection compatible with Female luer lock connection
+ Proximal end Bayonet system Compatible with qimo & with any Male Luer (lock or slip)
Set up to secure disconnection of an IV line
Device
code
Other set up
code Units per
qimo 7210.91
Connection to main infusion line
Safe double lumen IV extension for continuous infusion, intermittent injection and blood sampling through the lateral side port fitted with qimo
High pressure (240 PSI 16,5 bar)
Bi-directionnal valve with split septum closes at disconnection universal luer for intermittent injection or blood sampling
qimo
Securing your IV lines to protect your personal from cytotoxic exposure
+ Valve à déplacement neutre
Disconnection
When disconnecting qimo from qimo , no blood penetrates the catheter thus preventing catheter tip occlusion & reducting intraluminal germ colonization
qimo IV set includes :
qimoprime & qimo to prime the whole set.
1, 2 or 4 female, luer-compatible injection ports
an airvented spike and integrated filter
a Robert clamp
a drip chamber
a roller clamp
* qimo IV set can be supplied with or without Qimoctopus assembled on the IV line tubing.
Qimono
IV bag extension with a lateral injection site for connection to the main infusion line
Available with or without 0.2 μm particle filter Roberts clamp for quick closure qimo to secure distal end of the extension tube.
Available with 1, 2 or 4 lateral ports
luer-compatible injection ports
Spike with ventilation
Roberts clamp for quick closure
(1) Connor TH, Lawson CC, Polovich M, McDiarmid MA. Reproductive health risks associated with occupational exposures to antineoplastic drugs in health care settings: a review of the evidence. J Occup Environ Med. 2014.
(2) Hansen J, Olsen JH. Cancer morbidity among Danish female pharmacy technicians. Scand J Work Environ Health. 1994.
(3) Sylvia B. Bartel, Timothy G. Tyler, Luci A. Power, Am J Health Syst Pharm, 2018
(4) Preventing Occupational Exposures to Antineoplastic and other Hazardous Drugs in Health Care Settings, National Institute for Occupational Safety and Health (NIOSH), September 2004.
(5) ISOPP Standards of Practice: safe handling of cytotoxics - Section 7 Medical devices, International Society of Oncology Pharmacy Practitioners (ISOPP), J Oncol Pharm Pract, 2007.
(6) USP General Chapter <800> Hazardous Drugs-Handling in Healthcare Settings, United States Pharmacopeial Convention (USP), 2017.
(7) Preventing occupational exposure to cytotoxic and other hazardous drugs – European Policy Recommendations, European Parliament, 2016.
FOR FURTHER INFORMATION, PLEASE CONTACT: questions@vygon.com
The specification shown in this leaflet are for information only and are not, under any circumstances, of a contractual nature.
